Insights
Starting January 1, 2027, the 340B landscape may shift following the Health Resources and Services Administration’s (HRSA) implementation of the revised 340B Rebate Model Pilot Program Pilot Program
Pages
Pages
Pages
Insights
This study assesses the impact of an integrated health system specialty pharmacy model on GLP-1 RA access and adherence in adult patients with obesity.
Insights
This study assesses the patient perception of treatment experience observed during routine specialty pharmacy interactions among tafamidis-treated ATTR-CM patients.
Insights
This study assesses the pharmacist impact within an ATTR-CM specialty program by characterizing documented interventions and associated outcomes.
Insights
This study assesses the impact of a structured approach to increase engagement with health system specialty pharmacy patients who were previously lost to follow up.
Pages
Pages
Insights
This poster explores the ability of integrated health system specialty pharmacies to mitigate barriers faced by patients taking Glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Insights
This study assess the impact of a health system specialty pharmacy program on operational and clinical outcomes for patients on hGH.
